Northwest Biotherapeutics
CompanyUnited States
Northwest Biotherapeutics develops one asset. Mostly vaccine; based in the United States.
- 1
- Asset
- Furthest stage
- Not known
- 0
- Trials
- 1
- Signal
Pipeline
1Autologous dendritic cells loaded with tumor lysate stimulate an immune response against tumor antigens.
Stage not known, Vaccine
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials2
- Signals1